4-(BENZOIMIDAZOL-2-YL)-THIAZOLE COMPOUNDS AND RELATED AZA DERIVATIVES
申请人:Actelion Pharmaceuticals Ltd.
公开号:EP2809668B1
公开(公告)日:2017-04-12
US9266876B2
申请人:——
公开号:US9266876B2
公开(公告)日:2016-02-23
4-(Benzoimidazol-2-yl)-thiazole Compounds and Related Aza Derivatives
申请人:Actelion Pharmaceuticals Ltd.
公开号:US20140371204A1
公开(公告)日:2014-12-18
The invention relates to compounds of Formula (I) wherein ring A, X, (R
1
)
n
, R
2
, R
3
, R
4
, R
4′
, R
5
, n, and p are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
[EN] 4-(BENZOIMIDAZOL-2-YL)-THIAZOLE COMPOUNDS AND RELATED AZA DERIVATIVES<br/>[FR] COMPOSÉS DE 4-(BENZOIMIDAZOL-2-YLE)-THIAZOLE ET DÉRIVÉS AZA ASSOCIÉS
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2013114332A1
公开(公告)日:2013-08-08
The invention relates to compounds of Formula (I) wherein ring A, X, (R1)n, R2, R3, R4, R4', R5, n, and p are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.